Obesity

Showing NaN - NaN of 50

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Life-Style Modification On Ablation Outcome in Atrial

Recruiting
  • Atrial Fibrillation
  • Obesity
  • radiofrequency catheter ablation
  • Austin, Texas
    Texas Cardiac Arrhythmia Institute, St. david's Medical Center
Sep 9, 2019

Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

Completed
  • Cardiovascular Disease
  • +4 more
  • Lorcaserin hydrochloride
  • Placebo
  • Alexander City, Alabama
  • +498 more
Jun 27, 2019

Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Fatigue Trial in Korea, Republic of, United States

Unknown status
  • Endometrial Clear Cell Adenocarcinoma
  • +6 more
  • 3-Dimensional Conformal Radiation Therapy
  • +7 more
  • Birmingham, Alabama
  • +539 more
Mar 8, 2019

Obesity, Weight Gain, Eating Disorders Trial in Corvallis, Eugene, Austin (Healthy Weight, Project Health, Placebo Control)

Completed
  • Obesity
  • +2 more
  • Healthy Weight
  • +2 more
  • Corvallis, Oregon
  • +3 more
Sep 19, 2018

Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • Birmingham, Alabama
  • +225 more
Dec 20, 2017

Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • Vestavia Hills, Alabama
  • +160 more
Dec 6, 2017

Eating Frequency and Visceral Adipose Tissue, Body Fat, and

Completed
  • Obesity
  • +5 more
    • Austin, Texas
      University of Texas at Austin
    Oct 20, 2017

    Eating Disorders, Obesity Trial in United States (Body Project)

    Completed
    • Eating Disorders
    • Obesity
    • Body Project
    • Eugene, Oregon
    • +6 more
    Sep 29, 2016

    Obesity Trial in Austin (BioEnterics® Intragastric Balloon, Behavioral modification)

    Completed
    • Obesity
    • BioEnterics® Intragastric Balloon
    • Behavioral modification
    • Austin, Texas
      Apollo Endosurgery
    Oct 8, 2015

    Portable Body Scanner for Determination of Obesity

    Completed
    • Obesity
      • Austin, Texas
        The Uniersity of Texas at Austin
      Jun 23, 2015

      Obesity Trial in United States (pramlintide acetate, )

      Completed
      • Obesity
      • pramlintide acetate
      • placebo
      • Chula Vista, California
      • +20 more
      Jun 10, 2015

      Obesity Trial in United States (Placebo, Pramlintide and Metreleptin)

      Completed
      • Obesity
      • Placebo
      • Pramlintide and Metreleptin
      • Birmingham, Alabama
      • +32 more
      Mar 26, 2015

      Overweight, Obesity Trial in United States (pramlintide acetate, metreleptin, -P)

      Completed
      • Overweight
      • Obesity
      • pramlintide acetate
      • +3 more
      • Birmingham, Alabama
      • +35 more
      Mar 26, 2015

      Obesity Trial in United States (Pramlintide+Metreleptin, Placebo)

      Terminated
      • Obesity
      • Greenbrae, California
      • +17 more
      Mar 26, 2015

      Obesity Trial in United States (pramlintide acetate)

      Completed
      • Obesity
      • pramlintide acetate
      • Chula Vista, California
      • +20 more
      Apr 9, 2015

      Overweight, Obesity Trial in United States (pramlintide acetate, sibutramine, phentermine)

      Completed
      • Overweight
      • Obesity
      • pramlintide acetate
      • +3 more
      • Birmingham, Alabama
      • +15 more
      Mar 5, 2015

      Obesity, Overweight Trial in United States (AC2307, )

      Completed
      • Obesity
      • Overweight
      • Birmingham, Alabama
      • +17 more
      Jan 16, 2015

      Obesity, Overweight Trial in United States (Naltrexone SR 16 mg/Bupropion SR 360 mg /day, Naltrexone SR 32 mg/Bupropion SR 360

      Completed
      • Obesity
      • Overweight
      • Naltrexone SR 16 mg/Bupropion SR 360 mg /day
      • +3 more
      • Birmingham, Alabama
      • +33 more
      Nov 18, 2014

      Diabetes, Type 2, Obesity Trial in Worldwide (Placebo, BI 10773)

      Completed
      • Diabetes Mellitus, Type 2
      • Obesity
      • Placebo
      • BI 10773
      • Birmingham, Alabama
      • +102 more
      May 16, 2014

      Obesity Trial in Canada, United States (CP-945,598 Treatment A, CP-945,598 Treatment B, Placebo)

      Terminated
      • Obesity
      • CP-945,598 Treatment A
      • +2 more
      • Fairhope, Alabama
      • +81 more
      Nov 5, 2012

      Obesity Trial in United States (VI-0521, Placebo matched phentermine/topiramate)

      Completed
      • Obesity
      • VI-0521
      • Placebo matched phentermine/topiramate
      • San Diego, California
      • +4 more
      Sep 5, 2012

      Obesity, Type 2 Diabetes Trial in United States (VI-0521)

      Completed
      • Obesity
      • Type 2 Diabetes
      • Birmingham, Alabama
      • +5 more
      Sep 5, 2012

      Obesity Trial in Austin (BMS-830216, Placebo)

      Completed
      • Obesity
      • Austin, Texas
        Ppd Development, Lp
      Feb 22, 2011

      Obesity, Weight Loss Trial in Canada, United States (Rimonabant (SR141716))

      Completed
      • Obesity
      • Weight Loss
      • Rimonabant (SR141716)
      • Birmingham, Alabama
      • +50 more
      Apr 17, 2009

      Obesity Trial in United States (Nasal Placebo, Placebo Capsule, PYY3-36)

      Completed
      • Obesity
      • Nasal Placebo
      • +3 more
      • Peoria, Arizona
      • +28 more
      Sep 12, 2008